Global healthcare company Phillips-Medisize has showcased its expertise in drug delivery and connected devices this week at the 8th Annual InnoPack Pharma Confex.
Innovations
The company has been discussing the latest breakthroughs in drug delivery and demonstrating how its connected health solutions and powerful analytics are helping to improve patient engagement and adherence.
Speaking on the show’s first day, chief technology officer Bill Welch spoke to pharma companies on how to reach the market faster and expedite product development with proven technology accelerators for all types of infusion, injection and inhalation devices. His presentation – “Transforming Drug Delivery”, explained how to gain a competitive edge with human-centred design for customisable and user-friendly devices along with technology solutions that support global commercialisation.
More so, a panel discussion moderated by Welch on day two (22 May) looked at how to address the role of connected drug delivery devices for patient use in healthcare settings. The company also participated in a Packaging Leaders Roundtable where top industry experts deliberated critical areas of pharma packaging and drug delivery.
“Our primary business focus is on complex, regulated drug delivery devices and connected health solutions,” Welch said. “Together with our customers, we challenge and push the limits of product design and development to help transform the diagnosis and delivery of healthcare.”
To support the Indian market, the company created its Global Innovation and Development (GID) centre in Bangalore, supporting customers in the region working on intelligent drug delivery solutions.
“The added focus on healthcare in our India-based office, hiring of a senior business development director and continued investment in staff demonstrates our dedication to providing the right expertise, solutions and services that make a difference to our valued customers and their patients,” added Matt Jennings, CEO and President of Phillips-Medisize.